PhaseBio Pharmaceuticals, Inc. (PHAS)
R&D Expenses
-$14.31M
TTM · Period ending: · USD
PHAS R&D Expenses
Latest reported-$14.31Mperiod ending
Latest reported-$14.31Mperiod ending
PHAS R&D Expenses ($7.38M → -$14.31M)
Annual R&D Expenses
High-resolution chart · PNG
PHAS r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 102,107 | |
| 72,088,000 | |
| 30,911,000 | |
| 15,455,000 | |
| 6,210,000 | |
| 7,376,000 |